Kubo M - Search Results

1

Elevated circulating soluble CD30 levels in patients with polymyositis/dermatomyositis.

Yazawa N, Ihn H, Yamane K, Kubo M, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Yazawa N, et al. Among authors: kubo m. Br J Dermatol. 2001 Oct;145(4):676-8. doi: 10.1046/j.1365-2133.2001.04417.x. Br J Dermatol. 2001. PMID: 11703306 No abstract available.

2

Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Yamane K, Yazawa N, Kikuchi K, Soma Y, Tamaki K. Kubo M, et al. Br J Dermatol. 2000 Aug;143(2):392-8. doi: 10.1046/j.1365-2133.2000.03668.x. Br J Dermatol. 2000. PMID: 10951151

3

The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.

Kubo M, Ihn H, Yamane K, Tamaki K. Kubo M, et al. Br J Dermatol. 2006 May;154(5):919-25. doi: 10.1111/j.1365-2133.2005.06904.x. Br J Dermatol. 2006. PMID: 16634896

4

Distribution of anti-p80-coilin autoantibody in collagen diseases and various skin diseases.

Fujimoto M, Kikuchi K, Tamaki T, Yazawa N, Kubo M, Ihn H, Sato S, Soma Y, Tamaki K. Fujimoto M, et al. Among authors: kubo m. Br J Dermatol. 1997 Dec;137(6):916-20. Br J Dermatol. 1997. PMID: 9470907

5

Serum concentrations of vascular endothelial growth factor in collagen diseases.

Kikuchi K, Kubo M, Kadono T, Yazawa N, IHN H, Tamaki K. Kikuchi K, et al. Among authors: kubo m. Br J Dermatol. 1998 Dec;139(6):1049-51. doi: 10.1046/j.1365-2133.1998.02563.x. Br J Dermatol. 1998. PMID: 9990370

6

Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Yazawa N, Sato S, Kikuchi K, Tamaki K. Kubo M, et al. J Invest Dermatol. 1999 May;112(5):711-5. doi: 10.1046/j.1523-1747.1999.00580.x. J Invest Dermatol. 1999. PMID: 10233761 Free article.

7

Dermatomyositis with elevated serum hyaluronate.

Kubo M, Ihn H, Matsukawa A, Kikuchi K, Tamaki K. Kubo M, et al. Clin Exp Dermatol. 1999 Jul;24(4):275-8. doi: 10.1046/j.1365-2230.1999.00478.x. Clin Exp Dermatol. 1999. PMID: 10457129

8

Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.

Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Ihn H, et al. Among authors: kubo m. J Rheumatol. 2000 Mar;27(3):698-702. J Rheumatol. 2000. PMID: 10743811

9

Serum KL-6 in adult patients with polymyositis and dermatomyositis.

Kubo M, Ihn H, Yamane K, Kikuchi K, Yazawa N, Soma Y, Tamaki K. Kubo M, et al. Rheumatology (Oxford). 2000 Jun;39(6):632-6. doi: 10.1093/rheumatology/39.6.632. Rheumatology (Oxford). 2000. PMID: 10888708

10

Differential expression of transforming growth factor-beta receptors in squamous cell carcinoma.

Kubo M, Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K. Kubo M, et al. Br J Dermatol. 2001 Nov;145(5):840-2. doi: 10.1046/j.1365-2133.2001.04480.x. Br J Dermatol. 2001. PMID: 11736915 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,749 results

Search Page

Filters